Ropes Wealth Advisors’s 10x Genomics TXG Stock Holding History

Ropes Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$380K	Hold	9,212	–	–	0.07%	186
2023 Q2	$514K	Buy	9,212 +2,395	+35%	+$130K	0.09%	170
2023 Q1	$380K	Sell	6,817 -2,954	-30%	-$138K	0.07%	197
2022 Q4	$356K	Hold	9,771	–	–	0.06%	200
2022 Q3	$278K	Sell	9,771 -132	-1%	-$5.03K	0.06%	202
2022 Q2	$448K	Hold	9,903	–	–	0.09%	181
2022 Q1	$753K	Hold	9,903	–	–	0.13%	146
2021 Q4	$1.48M	Buy	9,903 +132	+1%	+$20.2K	0.26%	87
2021 Q3	$1.42M	Buy	9,771 +554	+6%	+$95.1K	0.23%	92
2021 Q2	$1.8M	Sell	9,217 -1,455	-14%	-$263K	0.29%	80
2021 Q1	$1.47M	Buy	10,672 +5,429	+104%	+$938K	0.26%	90
2020 Q4	$742K	Buy	5,243 +2,597	+98%	+$377K	0.12%	121
2020 Q3	$330K	Buy	+2,646	New	+$278K	0.06%	167

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ropes Wealth Advisors's TXG Position: Q3 2023 in Review

Ropes Wealth Advisors held its 10x Genomics (TXG) position steady in Q3 2023 at 9,212 shares worth $380K. The position accounts for 0.07% of the portfolio, ranked #186.

Ropes Wealth Advisors first reported a position in TXG in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.8M in Q2 2021. 256 funds tracked by Wall St. Rank hold TXG as of Q3 2023.

Ropes Wealth Advisors held 9,212 shares of 10x Genomics worth $380K as of Q3 2023.
Ropes Wealth Advisors left its 10x Genomics share count unchanged in Q3 2023.
10x Genomics made up 0.07% of Ropes Wealth Advisors's portfolio in Q3 2023, its #186 holding.
Ropes Wealth Advisors first reported a position in 10x Genomics in Q3 2020 and has held it in 13 quarters since.
Ropes Wealth Advisors's 10x Genomics position peaked at $1.8M in Q2 2021.
256 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2023.

Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.